Status:
TERMINATED
Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Respiratory Failure
Ventilatory Failure
Eligibility:
All Genders
18+ years
Brief Summary
This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation as...
Eligibility Criteria
Inclusion
- Admitted to the hospital
- ≥ 18 years of age
- Clinically suspected or confirmed COVID-19 infection
- Spontaneously breathing
- For patients not on supplemental oxygen at their location of residence prior to hospital admission, need for supplemental O2 to maintain SpO2 \>=92%
- For patients on supplemental O2 at their location of residence prior to hospital admission, an increase in requirement of supplemental oxygen from baseline
Exclusion
- Intubated patients
- Pregnant women
- Moribund patients
- Patients who are on comfort measures (CMO)
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04356443
Start Date
April 15 2020
End Date
December 31 2020
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114